ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CARM Carisma Therapeutics Inc

1.38
0.01 (0.73%)
May 17 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Carisma Therapeutics Inc CARM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.73% 1.38 18:58:24
Open Price Low Price High Price Close Price Previous Close
1.42 1.35 1.42 1.41 1.37
more quote information »

Recent News

Date Time Source Heading
5/16/202406:30PRNUSCarisma Therapeutics Announces First Patient Dosed in Phase..
5/09/202406:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:41EDGAR2Form 8-K - Current report
5/09/202406:30PRNUSCarisma Therapeutics Reports First Quarter 2024 Financial..
5/08/202410:45BWCarmila: Withdrawal of funds for the liquidity contract
5/08/202406:30PRNUSCarisma Therapeutics Presents Preclinical Proof of Concept..
5/07/202410:45BWCARMILA: Information Concerning the Total Number of Voting..
5/06/202406:30PRNUSCarisma Therapeutics to Participate in The Citizens JMP Life..
5/02/202406:30PRNUSCarisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief..
4/24/202416:05PRNUSCarisma Therapeutics Announces Upcoming Presentation at the..
4/24/202411:43BWCarmila : Lancement d’un programme de rachat d’actions pour..
4/22/202415:35PRNUSCarisma Therapeutics to Present New Data at the American..
4/17/202410:45BWCarmila: First-quarter 2024 Financial Information
4/05/202410:45BWCarmila : Informations relatives au nombre total de droits..
4/03/202406:00PRNUSCarisma Therapeutics to Present at Upcoming Conferences
4/01/202407:35PRNUSCarisma Therapeutics Provides Business Update and Reports..
4/01/202406:00PRNUSCarisma Therapeutics Announces Changes to its Board of..
3/21/202416:00PRNUSCarisma Announces Upcoming Presentations at the American..
3/15/202411:45BWCarmila: Filing of the 2023 Universal Registration Document
3/08/202410:45BWCORRIGE ET REMPLACE : Carmila : Evolution de la composition..
3/07/202415:05EDGAR2Form SC 13D/A - General statement of acquisition of..
3/07/202412:13BWCARMILA: Changes in the composition of the Board of..
3/04/202410:45BWCarmila : Informations relatives au nombre total de droits..
2/28/202406:30PRNUSCarisma Therapeutics to Participate in TD Cowen's 44th..
2/13/202410:45BWCarmila: 2023 Annual Results
2/02/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/02/202410:45BWCARMILA: Information Concerning the Total Number of Voting..
1/16/202410:45BWCarmila: Resources Devoted to the Liquidity Contract as of..
1/08/202410:57BWCARMILA: Information Concerning the Total Number of Voting..
12/21/202306:00PRNUSCarisma Therapeutics to Present at the 42nd Annual J.P...
12/14/202306:00PRNUSFirst In Vivo CAR-M Lead Candidate Nominated Under..
12/05/202310:45BWCarmila : Informations relatives au nombre total de droits..
11/28/202306:00PRNUSCarisma Therapeutics Announces FDA Clearance of IND..
11/22/202306:30PRNUSCarisma Therapeutics to Participate in Evercore ISI..
11/10/202313:17BWCarmila: Termination of Liquidity Contract With BNP Paribas..
11/09/202310:45BWCARMILA : Informations relatives au nombre total de droits..
11/09/202307:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:42EDGAR2Form 8-K - Current report
11/09/202306:30PRNUSCarisma Therapeutics Reports Third Quarter 2023 Financial..
10/31/202308:25PRNUSCarisma Presents Pre-Clinical Proof of Concept for in vivo..
10/25/202308:11PRNUSCarisma to Present First Results From in vivo CAR-M..
10/20/202310:47BWCarmila: Financial Information as of 30 September 2023
10/02/202311:35BWCarmila : Emission d’un emprunt obligataire de 500 millions..
10/02/202310:45BWCARMILA : Informations relatives au nombre total de droits..
9/05/202307:30PRNUSCarisma Therapeutics to Present at Upcoming Investor..
9/01/202310:45BWCARMILA : Informations relatives au nombre total de droits..
9/01/202308:05EDGAR2Form 8-K - Current report
9/01/202307:30PRNUSCarisma Announces Latest Data from Phase 1 Clinical Trial of..
8/24/202307:30PRNUSCarisma Therapeutics to Present at Upcoming Healthcare..